• Explore /
  • Poster
  • / Comparison of<span> abiraterone acetate (Abi) versus ketoconazole (Keto) in </span>chemotherapy-naive patients (CN-pts) with metastatic castration resistant prostate cancer (mCRPC).

Comparison of abiraterone acetate (Abi) versus ketoconazole (Keto) in chemotherapy-naive patients (CN-pts) with metastatic castration resistant prostate cancer (mCRPC).

Abstract Poster

Authors

null

Avivit Peer

Rambam Health Care Campus, Haifa, Israel

Avivit Peer , Avivit Neumann , Avishay Sella , Eli Rosenbaum , Victoria Neiman , Maya Gottfried , Iryna Kuchuk , Svetlana Kovel , David Sarid , Eliahu Gez , Wilmosh Mermershtain , Keren Rouvinov , Michael Anthony Carducci , Mario A. Eisenberger , Victoria J. Sinibaldi , Raanan Berger , Daniel Keizman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 260)

DOI

10.1200/jco.2016.34.2_suppl.260

Abstract #

260

Poster Bd #

L9

Abstract Disclosures

Similar Posters

First Author: Jacob A Gordon

First Author: Arun Azad

First Author: Antoine Angelergues

First Author: Victoria J. Sinibaldi